BLOOD STOP DRUGS IN EMERGENCY MEDICAL CARE
Keywords:
Blood , Drug , Gastrointestinal , ThrombinAbstract
Dear reader, in this article you can get information about what drugs we can help faster if we use to provide first aid at the time of bleeding, one of the most frequent cases of the moment
References
Miller CS, Grandi SM, Shimony A, et al. Meta-analysis of efficacy and safety of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus warfarin in patients with atrial fibrillation. Am J Cardiol. 2012;110(3):453-460.
Kamal AH, Tefferi A, Pruthi RK. How to interpret and pursue an abnormal prothrombin time, activated partial thromboplastin time, and bleeding time in adults. Mayo Clin Proc. 2007;82(7):864-873.
Dager WE, Gosselin RC, Kitchen S, et al. Dabigatran effects on the international normalized ratio, activated partial thromboplastin time, thrombin time, and fibrinogen: A multicenter, in vitro study. Ann Pharmacother. 2012;46(12):1627-1636.
Sambu N, Curzen N. Monitoring the effectiveness of antiplatelet therapy: Opportunities and limitations. Br J Clin Pharmacol. 2011;72(4):683-696.
Costa-Lima C, Fiusa MM, Annichino-Bizzacchi JM, et al. Prothrombin complex concentrates in warfarin anticoagulation reversal. Rev Bras Hematol Hemoter. 2012;34(4):302-304.
Franchini M, Lippi G. Prothrombin complex concentrates: An update. Blood Transfus. 2010;8(3):149-154.
Leissinger CA, Blatt PM, Hoots WK, et al. Role of prothrombin complex concentrates in reversing warfarin anticoagulation: A review of the literature. Am J Hematol. 2008;83(2):137-143.
Johansen M, WikkelsภA, Lunde J, et al. Prothrombin complex concentrate for reversal of vitamin K antagonist treatment in bleeding and non-bleeding patients. Cochrane Database Syst Rev. 2015;(7):CD010555.
Radaelli F, Dentali F, Repici A, et al. Management of anticoagulation in patients with acute gastrointestinal bleeding. Dig Liver Dis. 2015;47(8):621-627.
Pollack CV Jr, Reilly PA, Eikelboom J, et al. Idarucizumab for dabigatran reversal. N Engl J Med. 2015;373(6):511-520.
Eerenberg ES, Kamphuisen PW, Sijpkens MK, et al. Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: A randomized, placebo-controlled, crossover study in healthy subjects. Circulation. 2011;124(14):1573-1579.
Connors JM. Antidote for Xa anticoagulants. N Engl J Med. 2015;373(25):2471-2472.
Alquwaizani M, Buckley L, Adams C, et al. Anticoagulants: A review of the pharmacology, dosing, and complications. Curr Emerg Hosp Med Rep. 2013;1(2):83-97.
Powner DJ, Hartwell EA, Hoots WK. Counteracting the effects of anticoagulants and antiplatelet agents during neurosurgical emergencies. Neurosurgery. 2005;57(5):823-831.
Naidech AM, Maas MB, Levasseur-Franklin KE, et al. Desmopressin improves platelet activity in acute intracerebral hemorrhage. Stroke. 2014;45(8):2451-2453.
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
